trending Market Intelligence /marketintelligence/en/news-insights/trending/i-vm7hzr4uyu-fu1yesiiw2 content esgSubNav
In This List

Avadel Pharmaceuticals adds director

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Avadel Pharmaceuticals adds director

Avadel Pharmaceuticals plc has appointed Kevin Kotler to the board, effective Dec. 11.

Kotler is the founder and portfolio manager of Broadfin Capital LLC and a director of BioDelivery Sciences International Inc.

Dublin-based Avadel Pharmaceuticals develops and commercializes pharmaceutical products primarily for treating urology and sleep medicines.